Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bites and Stings × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17 Pain 16 Cancer Pain 14 Pain, Postoperative 9 Chronic Pain 7 Agnosia 5 Colonic Neoplasms 4 Multiple Myeloma 3 Mucositis 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Breast Neoplasms 3 Wounds and Injuries 2 Waldenstrom Macroglobulinemia 2 Thrombocythemia, Essential 2 Supratentorial Neoplasms 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Polycythemia Vera 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Pancreatic Neoplasms 2 Pain, Intractable 2 Neoplastic Cells, Circulating 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2

Interventions

pembrolizumab 3 blinatumomab 2 Stents 2 soybean oil, phospholipid emulsion 1 enzalutamide 1 durvalumab 1 dostarlimab 1 cemiplimab 1 camrelizumab 1 atezolizumab 1 abiraterone 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Neoadjuvant Therapy 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Hydroxyurea 1 Etoposide 1 Etanercept 1 Cytochrome P-450 Enzyme System 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03165383 2017-05-24

TAP

Rajiv Gandhi Cancer Institute & Research Center, India

Phase NA Completed

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡